Atossa Therapeutics
ATOS
#10728
Rank
ยฃ18 M
Marketcap
ยฃ1.80
Share price
0.84%
Change (1 day)
156.05%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -ยฃ28.24 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ26.14 Million a decrease over its 2024 earnings that were of -ยฃ19.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ28.24 Million8.03%
2025 -ยฃ26.14 Million36.33%
2024 -ยฃ19.18 Million-15.25%
2023 -ยฃ22.63 Million11.62%
2022 -ยฃ20.27 Million30.84%
2021 -ยฃ15.49 Million15.58%
2020 -ยฃ13.41 Million3.41%
2019 -ยฃ12.96 Million51.16%
2018 -ยฃ8.58 Million40.41%
2017 -ยฃ6.11 Million27.54%
2016 -ยฃ4.79 Million-47.49%
2015 -ยฃ9.12 Million-17.25%
2014 -ยฃ11.02 Million35.91%
2013 -ยฃ8.11 Million112.3%
2012 -ยฃ3.82 Million46.53%
2011 -ยฃ2.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.70 B-69,600.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.05 B-3,823.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.09 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.33 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ39.07 Million 37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.9 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA